CAS 2247614-80-6

1H-1,2,3-Triazole-4-carboxamide, 1-(1,1-dimethylethyl)-N-[(5R)-2,3,4,5-tetrahydro-8-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-2-(3-oxetanyl)-1H-2-benzazepin-5-yl]-

Description:

1H-1,2,3-Triazole-4-carboxamide, 1-(1,1-dimethylethyl)-N-[(5R)-2,3,4,5-tetrahydro-8-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-2-(3-oxetanyl)-1H-2-benzazepin-5-yl]- is a complex organic compound characterized by its triazole and carboxamide functional groups, which contribute to its potential biological activity. The presence of a triazole ring suggests possible applications in medicinal chemistry, particularly in the development of antifungal and antibacterial agents. The compound also features a bulky tert-butyl group, which may influence its solubility and bioavailability. Additionally, the structure includes a tetrahydro-benzazepine moiety, which is often associated with neuroactive properties. The presence of multiple heterocycles, such as pyrazole and pyrimidine, indicates potential interactions with various biological targets, making it a candidate for further pharmacological studies. Overall, this compound's unique structural features may provide insights into its reactivity, stability, and potential therapeutic applications.

Formula: C₂₈H₃₄N₁₀O₂

Synonyms:

• BIIB091
• 1H-1,2,3-Triazole-4-carboxamide, 1-(1,1-dimethylethyl)-N-[(5R)-2,3,4,5-tetrahydro-8-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-2-(3-oxetanyl)-1H-2-benzazepin-5-yl]-

BIIB091

CAS: 2247614-80-6

BIIB091 is a highly selective, reversible BTK inhibitor for treating autoimmune diseases.

Formula: C₂₈H₃₄N₁₀O₂

Color and Shape: Solid

Molecular weight: 542.648

Ref: TM-T39761